Trastuzumab As Adjuvant Therapy In Her2+ Early Breast Cancer - Cardiac Safety Analysis
AuthID
P-003-23B
P-003-23B
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service